Literature DB >> 18322947

Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy.

Xian-Ming Lin1, Ying-Bin Liu, Fan Zhou, Yu-Lian Wu, Li Chen, He-Qing Fang.   

Abstract

AIM: To study the expression of tumor necrosis factor-alpha converting enzyme (TACE) and evaluate its significance in liver regeneration after partial hepatectomy in vivo.
METHODS: Male SD rats underwent 70% partial hepatectomy. The remaining liver and spleen tissue samples were collected at indicated time points after hepatectomy. TACE expression was investigated by Western blotting, immunohistochemistry, and serial section immunostaining.
RESULTS: Expression of TACE in liver and spleen tissues after partial hepatectomy was a time-dependent alteration, reaching a maximal level between 24 and 48 h and remaining elevated for more than 168 h. TACE protein was localized to mononuclear cells (MNC), which infiltrated the liver from the spleen after hepatectomy. The kinetics of TACE expression was in accordance with the number of TACE-staining MNCs and synchronized with those of transforming growth factor-alpha (TGFalpha). In addition, TACE-staining MNC partially overlapped with CD3+ T lymphocytes.
CONCLUSION: TACE may be involved in liver regeneration by pathway mediated with TGFalpha-EGFR in the cell-cycle progressive phase in vivo. TACE production and effect by paracrine may be a pathway of involvement in liver regeneration for the activated CD3+ T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322947      PMCID: PMC2693681          DOI: 10.3748/wjg.14.1353

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats.

Authors:  T Uemura; M Miyazaki; R Hirai; H Matsumoto; T Ota; R Ohashi; N Shimizu; T Tsuji; Y Inoue; M Namba
Journal:  Int J Mol Med       Date:  2000-02       Impact factor: 4.101

2.  Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

Authors:  Susan Wohler Sunnarborg; C Leann Hinkle; Mary Stevenson; William E Russell; Christina S Raska; Jacques J Peschon; Beverly J Castner; Mary J Gerhart; Raymond J Paxton; Roy A Black; David C Lee
Journal:  J Biol Chem       Date:  2002-01-31       Impact factor: 5.157

3.  Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration.

Authors:  T H Kim; W M Mars; D B Stolz; G K Michalopoulos
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

4.  Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation.

Authors:  M Minagawa; H Oya; S Yamamoto; T Shimizu; M Bannai; H Kawamura; K Hatakeyama; T Abo
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.

Authors:  T Sakairi; K Kobayashi; K Goto; M Okada; M Kusakabe; T Tsuchiya; J Sugimoto; F Sano; M Mutai
Journal:  Toxicol Pathol       Date:  2001 Jul-Aug       Impact factor: 1.902

6.  TACE is required for the activation of the EGFR by TGF-alpha in tumors.

Authors:  Maria Borrell-Pagès; Federico Rojo; Joan Albanell; Josep Baselga; Joaquín Arribas
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.

Authors:  Gretchen M Argast; Jean S Campbell; John T Brooling; Nelson Fausto
Journal:  J Biol Chem       Date:  2004-06-15       Impact factor: 5.157

8.  Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo.

Authors:  Hiroyasu Ito; Kazuki Ando; Toshinori Nakayama; Masaru Taniguchi; Takayuki Ezaki; Kuniaki Saito; Masao Takemura; Kenji Sekikawa; Michio Imawari; Mitsuru Seishima; Hisataka Moriwaki
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

9.  Immunohistochemical localization of transforming growth factor alpha in regenerating rat liver.

Authors:  Miyoko Okada; Tetsuya Sakairi; Manami Kusakabe; Kazuhiro Goto; Takayuki Tsuchiya; Jiro Sugimoto; Fumiko Sano; Mamoru Mutai; Tetsuo Morohashi; Kiyoshi Kobayashi
Journal:  J Vet Med Sci       Date:  2002-11       Impact factor: 1.267

Review 10.  TACE: a new target in epidermal growth factor receptor dependent tumors.

Authors:  Paraic A Kenny
Journal:  Differentiation       Date:  2007-07-02       Impact factor: 3.880

View more
  5 in total

1.  High-throughput analysis of tumor necrosis factor signaling pathways in eight cell types during rat hepatic regeneration.

Authors:  Xiaoguang Chen; Cunshuan Xu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  A disintegrin and metalloproteinase 17 regulates TNF and TNFR1 levels in inflammation and liver regeneration in mice.

Authors:  Ryan S McMahan; Kimberly J Riehle; Nelson Fausto; Jean S Campbell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-02       Impact factor: 4.052

3.  EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration.

Authors:  Alexandra Collin de L'hortet; Hélène Gilgenkrantz; Jacques-Emmanuel Guidotti
Journal:  Int J Hepatol       Date:  2012-09-23

Review 4.  EGFR Signaling in Liver Diseases.

Authors:  Karin Komposch; Maria Sibilia
Journal:  Int J Mol Sci       Date:  2015-12-29       Impact factor: 5.923

5.  Detection of telomerase reverse transcriptase mRNA in peripheral blood mononuclear cells of patients with liver failure.

Authors:  Zhu Chuanwu; Qian Feng; Li Ming; Wang Haiyan; Fang Huan; Luo Xiangrong; Zhang Xuehua; Zhu Xiang; Shen Xiujuan; Xu Ping
Journal:  Hepat Mon       Date:  2014-04-14       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.